tecovirimat

A potent and specific inhibitor of orthopoxvirus replication. It is used for the treatment of SMALLPOX and other orthopoxvirus infections, including MONKEYPOX under expanded access investigational new drug protocol (https://www.cdc.gov/poxvirus/monkeypox/clinicians/Tecovirimat.html).

Also Known As:

4- trifluoromethyl- N- (3,3a,4,4a,5,5a,6,6a- octahydro- 1,3- dioxo- 4,6- ethenocycloprop(f)isoindol- 2(1H)- yl)- benzamide; N- ((3aR,4R,4aR,5aS,6S,6aS)- 1,3- Dioxo- 3,3a,4,4a,5,5a,6,6a- octahydro- 4,6- ethenocyclopropa(f)isoindol- 2(1H)- yl)- 4- (trifluoromethyl)benzamide; SIGA-246; ST 246; ST-246; TPOXX; benzamide, N- ((3aR,4R,4aR,5aS,6S,6aS)- 3,3a,4,4a,5,5a,6,6a- octahydro- 1,3- dioxo- 4,6- ethenocycloprop(F)isoindol- 2(1H)- yl)- 4- (trifluoromethyl)- , hydrate (1:1), rel-; tecovirimat monohydrate

Organic Chemicals: 133
- Amides: 2428
  - Benzamides: 115
    - tecovirimat: 181
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzoates: 426
        Benzamides: 115
        tecovirimat: 181
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Benzoates: 426
      - Benzamides: 115
        tecovirimat: 181
    - Phthalic Acids: 1
      - Phthalimides: 12
        tecovirimat: 181
- Imides: 79
  - Phthalimides: 12
    - tecovirimat: 181
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Isoindoles: 18
      - Phthalimides: 12
        tecovirimat: 181

Peter Finin Selected Research

Peter Finin Research Topics

Disease

Drug/Important Bio-Agent (IBA)